By Fineline Cube China’s National Healthcare Security Administration (NHSA) has released a draft proposal titled “Work Plan for Developing the National Basic Medical Insurance (BMI) Medical Service Items List (First Batch),” inviting public feedback until June 3, 2026. This initiative marks a significant step toward standardizing medical service reimbursement across China’s vast healthcare system.
Policy Framework & Current Landscape
| Component | Current Status | Proposed Change |
|---|---|---|
| Drug List | National catalog with uniform application nationwide | No change |
| Medical Service Items | Locally managed with national exclusions only | National standardized catalog |
| Medical Consumables | Mixed approach varying by province | Potential future standardization |
| Reimbursement Scope | Defined by three separate lists | Unified national framework |
Currently, while China’s national drug catalog has achieved largely uniform application nationwide, medical service items have been managed at the provincial level, with local authorities determining actual coverage based on clinical needs, technological advances, and fund sustainability constraints.
Implementation Timeline & Strategy
- Current Progress: 29 provinces have already unified their provincial coverage catalogs for medical service items
- Initial Application: Catalog will first apply to inter-provincial patients to address cross-border healthcare challenges
- Gradual Expansion: Nationwide implementation will follow after initial pilot phase
- Public Consultation: Feedback period open until June 3, 2026, allowing stakeholders to influence final policy
Strategic Objectives & Market Impact
- Unified Domestic Market: Eliminates regional disparities in medical service coverage, creating consistent reimbursement standards across all 31 provincial-level administrative regions
- Insurance Fund Efficiency: Improves utilization of BMI funds through standardized pricing and coverage decisions
- Healthcare Equity: Enhances fairness, standardization, and consistency of basic medical insurance benefits regardless of patient location
- Provider Implications: Hospitals and clinics will benefit from predictable reimbursement rates and reduced administrative burden from managing multiple provincial policies
Industry Stakeholder Considerations
| Stakeholder Group | Impact | Strategic Response |
|---|---|---|
| Healthcare Providers | Simplified billing, standardized reimbursement | Prepare for uniform service definitions and pricing |
| Medical Technology Companies | Clearer pathway for service item inclusion | Engage during public consultation period |
| Pharmaceutical Companies | Indirect impact through integrated care pathways | Monitor potential spillover effects on drug utilization |
| Patients | Improved access to consistent care across provinces | Enhanced mobility without insurance coverage concerns |
The NHSA’s move follows successful implementation of national pricing guidelines for medical services, which have progressively harmonized the names and definitions of reimbursable services across the country, creating the foundation for this comprehensive catalog.
Forward-Looking Statements
This brief contains forward-looking statements regarding policy implementation, regulatory timelines, and market impacts. Actual outcomes may differ due to factors including stakeholder feedback, implementation challenges, and evolving healthcare priorities.-Fineline Info & Tech